Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.
Falzone L, Salomone S, Libra M. · 2018
Read Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. by Falzone L, Salomone S, Libra M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6243123.txt.
Introduction
Falzone, Salomone, and Libra trace how drug treatment for cancer has changed over time. Their review appeared in Frontiers in Pharmacology. Cancer care began with surgery and cautery in ancient times. X-rays brought the first modern drug free approach near the end of the 1800s. After the Second World War, cell killing drugs opened the chemotherapy era. Those drugs improved survival for many blood and solid cancers.
In the 1980s, cell and molecular biology led to drugs aimed at single targets. Genetic engineering then brought lab made antibodies into care. Drugs that free the immune system followed, helping some advanced cancers that had no good options. The authors close with cell therapies and cancer vaccines now in early tests. Each era built on the limits of the one before it.
Catalog record
| CREATOR | Falzone L, Salomone S, Libra M. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 143 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |